Skip to content
healthcare.dev

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

NDC 62135-696, Chlordiazepoxide Hydrochloride and Clidinium Bromide, capsule, from Chartwell RX, LLC.

Product NDC
62135-696
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213530
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-696 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORDIAZEPOXIDE HYDROCHLORIDE5 mg/1
  • CLIDINIUM BROMIDE2.5 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Benzodiazepine [EPC]; Benzodiazepines [CS]; Cholinergic Antagonists [MoA]; Decreased Parasympathetic Acetylcholine Activity [PE]; Digestive/GI System Activity Alteration [PE]; GI Motility Alteration [PE]

Package NDCNDC-11Package
62135-696-1262135069612120 CAPSULE in 1 BOTTLE (62135-696-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a0d735c2-e7a9-4843-a78d-203c9598682d
  • NADAC price for package 62135069612

    GET /v1/drugs/nadac/62135069612

Use it

Look up 62135-696 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-696 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-696. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.